Orphan Drug Congress 2012

As rare diseases affect only a tiny group of people, pursuing the development of treatments has traditionally not been attractive for pharma companies. In order to discuss major concerns, the newest solutions and challenges, Fleming Europe...

New component of cannabis discovery could lead to better treatments for epilepsy

Scientists at the University of Reading have demonstrated for the first time that a previously unstudied chemical in cannabis could lead to more effective treatments for people with epilepsy.

Breakthrough in Alzheimer’s Research

A drug used by diabetes sufferers could have the potential to treat neurodegenerative diseases like Alzheimer’s, a study by scientists at the University of Ulster has revealed.

Possible new therapy for the treatment of a common blood cancer

Research from Karolinska Institutet in Sweden shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common forms of blood cancer and...

Considerably more patients may benefit from effective antidiabetic drug

The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study has found that the risks have been substantially overrated. As a...

Scientists can now block heroin, morphine addiction

In a major breakthrough, an international team of scientists has proven that addiction to morphine and heroin can be blocked, while at the same time increasing pain relief.

Roche / Avastin study

Roche study showed that adding Avastin to radiation and chemotherapy significantly extended the time people with an aggressive form of brain cancer lived without their disease worsening.

Rising to the challenge of EVMPD

Sean Ottewell looks at the latest information management systems to administer new requirements concerning the collection, reporting, coding...

Study shows Avastin has similar effect to Lucentis

The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported at an international research...

Neuroscientists discover key protein responsible for controlling nerve cell protection

A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by...

Bristol researchers solve 70 year old mystery

Chemists and biologists from the University of Bristol have finally cracked one of the longest standing chemical mysteries. In a paper published today in PNAS, the team demonstrate exactly how an unusual class of compounds known as...

Discovery paves way for improved pain-killers

An international team of researchers has made a major discovery that could lead to more effective treatment of severe pain using morphine.

Innovative screening tools accelerate drug discovery

Exclusively available in the UK from Cambio, Transcreener® HTS Assays and iuvo Microconduit array technology meet a demand for high...

Biomarkers in Drug Discovery & Development

At this event in Berlin, participants will meet eminent representatives from big pharma companies such as Pfizer, Sanofi, Bayer, Janssen, Novartis as well as highly qualified experts from academia and research institutes. They are...

Scientists develop new strategy to overcome drug-resistant childhood cancer

A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.

US-Kent research aims to find a new treatment for migraine

A University of Kent-led clinical trial that aims to discover a potential new treatment for migraine through non-invasive neuro-stimulation is set to commence during late summer 2012.

University of Cambridge launches Open Innovation drug discovery initiative with GSK

The University of Cambridge is embarking on a programme of scientific open collaboration with GlaxoSmithKline (GSK) that will involve working alongside GSK scientists and other partner organisations, to advance drug discovery and the...

Roche and Seaside Therapeutics announce landmark alliance

Roche and Seaside Therapeutics announced that they have entered into a collaboration to develop disease modifying treatments for fragile X syndrome (FXS) and autism spectrum disorders (ASD), both neurodevelopmental disorders for which there...

Kill the germs, spare the ears

Study shows how to create effective antibiotics that don’t damage hearing.

Genetic discovery unlocks biosynthesis of medicinal compound in poppy

Scientists at the University of York and GlaxoSmithKline (GSK) Australia have discovered a complex gene cluster responsible for the synthesis of the medicinal compound noscapine.



Twitter Icon © Setform Limited